Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Minimal Residual Disease (MRD) Status after Induction Therapy Is a Strong Prognostic Factor in the Treatment of Adult Ph (-) Acute Lymphoblastic Leukemia (ALL): Results of a Prospective Study (ALL MRD2008 Study)

Koji Nagafuji, MD PhD, Toshihiro Miyamoto, MD PhD, Tetsuya Eto, MD PhD, Ryosuke Ogawa, MD PhD, Naoyuki Uchida, MD PhD, Ken Takase, MD, Noriaki Kawano, MD PhD, Tomoaki Fujisaki, MD PhD, Tomohiko Kamimura, MD PhD, Atsushi Wake, MD PhD, Hirokazu Okumura, MD PhD, Yasuhiko Miyazaki, MD PhD, Yasushi Takamatsu, MD PhD, Toshiro Kurokawa, MD PhD, Yuju Ohno, MD PhD, Shouhei Yokota, MP.Path, Koichi Akashi, MD PhD

Blood (2018) 132 (Supplement 1): 3970.

https://doi.org/10.1182/blood-2018-99-112848

Published: 2018

Journal Articles

Combining the Number of Infectious Episodes and Interval of Chemotherapy to Transplantation May Predict a Transplant Outcome in Patients with Acute Myeloid Leukemia: A Retrospective Analysis of JALSG AML201 Study

Satoshi Kaito, MD, Noriko Doki, MD PhD, Yuho Najima, MD, Shigeki Ohtake, MD PhD, Hitoshi Kiyoi, MD PhD, Hiroyuki Fujita, MD PhD, Yasushi Miyazaki, MD PhD, Noriko Usui, MD PhD, Hirokazu Okumura, MD PhD, Koichi Miyamura, MD PhD, Emiko Sakaida, MD PhD, Atsushi Fujieda, MD PhD, Nagai Tadashi, MD PhD, Takahisa Yamane, MD PhD, Ohnishi Kazunori, MD PhD, Tomoki Naoe, MD PhD, Kazuteru Ohashi, MD PhD

Blood (2018) 132 (Supplement 1): 4643.

https://doi.org/10.1182/blood-2018-99-114565

Published: 2018

Journal Articles

Phase III Randomized Study of Imatinib Therapy in Chronic Phase Chronic Myeloid Leukemia Comparing Standard Dose-Escalation with Progressive Dose-Escalation (JALSG CML207 study)

Koichi Miyamura, MD PhD, Shigeki Ohtake, MD PhD, Kazunori Ohnishi, MD PhD, Noriko Usui, MD PhD, Chiaki Nakaseko, MD PhD, Hiroyuki Fujita, MD PhD, Shin Fujisawa, MD PhD, Toru Sakura, MD, Hirokazu Okumura, Yoshihiro Hatta, MD PhD, Nobuhiko Emi, MD PhD, Tomoki Naoe, MD PhD

Blood (2016) 128 (22): 941.

https://doi.org/10.1182/blood.V128.22.941.941

Published: 2016

Journal Articles

Efficacy of Gemtuzumab Ozogamicin (GO) Monotherapy on Relapsed/Refractory Acute Promyelocytic Leukemia (APL)

Blood (2011) 118 (21): 1532.

https://doi.org/10.1182/blood.V118.21.1532.1532

Published: 2011

Journal Articles

Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 Study

Blood (2011) 117 (8): 2358–2365.

https://doi.org/10.1182/blood-2010-03-273243

Published: 2011

Journal Articles

Outcome by Treatment Including An Intensified Consolidation Program with Dose-Escalated Doxorubicin for Newly Diagnosed Acute Lymphoblastic Leukemia (ALL): A Study by the Japan Adult Leukemia Study Group (JALSG ALL97 study).

Itsuro Jinnai, MD, Tohru Sakura, MD, Motohiro Tsuzuki, MD, Yasuhiro Maeda, MD, PhD, Noriko Usui, MD, Masayuki Kato, MD, Hirokazu Okumura, MD, PhD, Yasunori Ueda, MD, Yuji Kishimoto, MD, Fumiharu Yagasaki, MD, Jin Takeuchi, MD, Masako Iwanaga, MD, Yasushi Miyazaki, MD, Shuichi Miyawaki, MD, Kazunori Ohnishi, MD, PhD, Tomoki Naoe, MD, Ph.D., Ryuzo Ohno, MD

Blood (2009) 114 (22): 4334.

https://doi.org/10.1182/blood.V114.22.4334.4334

Published: 2009

Journal Articles

C-Terminal Defect of CD20 on T-Cell Leukemia/Lymphoma Cells: Implications for Resistance to Rituximab

Hiroyuki Takamatsu, MD, PhD, Yoshihiro Yakushijin, MD, PhD, Koji Miyazaki, MD, PhD, Akiyoshi Takami, MD, PhD, Masahide Yamazaki, MD, PhD, Hirokazu Okumura, MD, PhD, Shinji Nakao, MD, PhD

Blood (2008) 112 (11): 5267.

https://doi.org/10.1182/blood.V112.11.5267.5267

Published: 2008

Journal Articles

Expansion of donor-derived hematopoietic stem cells with PIGA mutation associated with late graft failure after allogeneic stem cell transplantation

Kanako Mochizuki, Chiharu Sugimori, Zhirong Qi, Xuzhang Lu, Akiyoshi Takami, Ken Ishiyama, Yukio Kondo, Hirohito Yamazaki, Hirokazu Okumura, Shinji Nakao

Blood (2008) 112 (5): 2160–2162.

https://doi.org/10.1182/blood-2008-02-141325

Published: 2008

Includes: Supplemental data

Journal Articles

A Novel Strategy for the Treatment of Acute Graft-Versus-Host Disease Using the Adsorbent To Remove Excessive Inflammatory Cytokines.

Akiyoshi Takami, MD, PhD, Takanori Teshima, MD, PhD, Koshin Ushizaki, Takumi Taniguchi, MD, PhD, Tohru Endo, Hiroshi Sakurai, PhD, Yukio Kondo, MD, PhD, Hirohito Yamazaki, MD, PhD, Shigeru Shimadoi, MD, Hirokazu Okumura, MD, PhD, Shinji Nakao, MD, PhD

Blood (2007) 110 (11): 5001.

https://doi.org/10.1182/blood.V110.11.5001.5001

Published: 2007

Journal Articles

Monocyte Colony-Stimulating Factor Enhances Rituximab-Dependent Cellular Cytotoxicity by Monocytes.

Akiyoshi Takami, MD, PhD, FJSIM, Shigeru Shimadoi, MD, Yukio Kondo, MD, PhD, Hirokazu Okumura, MD, PhD, Shinji Nakao, MD, PhD

Blood (2006) 108 (11): 2533.

https://doi.org/10.1182/blood.V108.11.2533.2533

Published: 2006

Journal Articles

Clinical Analysis of Adult Acute Leukemia with Rearrangements of the 11q23/MLL: Multicenter Co-Operative Study.

Blood (2006) 108 (11): 2354.

https://doi.org/10.1182/blood.V108.11.2354.2354

Published: 2006

Journal Articles

Treatment Outcome of Aggressive Lymphoma with CyclOBEAP (CHOP-Like + Etoposide and Bleomycin): Results of Multicenter Trial.

Masataka Okamoto, M.D., Nozomi Niitsu, M.D., Sadao Aoki, M.D., Yasunobu Kuraishi, M.D., Hirokazu Okumura, M.D., Masami Hirano, M.D.

Blood (2004) 104 (11): 3303.

https://doi.org/10.1182/blood.V104.11.3303.3303

Published: 2004

Journal Articles

Disappearance of Cytogenetic Abnormalities Induced by Cyclosporine Therapy in a Case of Aplastic Anemia

Minoru Takeshima, Yasuhiro Mochizuki, Takashi Yoshida, Hideyuki Takamatsu, Hirokazu Okumura

Blood (1998) 91 (3): 1094–1095.

https://doi.org/10.1182/blood.V91.3.1094b

Published: 1998

NARROW

Minimal Residual Disease (MRD) Status after Induction Therapy Is a Strong Prognostic Factor in the Treatment of Adult Ph (-) Acute Lymphoblastic Leukemia (ALL): Results of a Prospective Study (ALL MRD2008 Study)

Combining the Number of Infectious Episodes and Interval of Chemotherapy to Transplantation May Predict a Transplant Outcome in Patients with Acute Myeloid Leukemia: A Retrospective Analysis of JALSG AML201 Study

Phase III Randomized Study of Imatinib Therapy in Chronic Phase Chronic Myeloid Leukemia Comparing Standard Dose-Escalation with Progressive Dose-Escalation (JALSG CML207 study)

Efficacy of Gemtuzumab Ozogamicin (GO) Monotherapy on Relapsed/Refractory Acute Promyelocytic Leukemia (APL)

Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 Study

Outcome by Treatment Including An Intensified Consolidation Program with Dose-Escalated Doxorubicin for Newly Diagnosed Acute Lymphoblastic Leukemia (ALL): A Study by the Japan Adult Leukemia Study Group (JALSG ALL97 study).

C-Terminal Defect of CD20 on T-Cell Leukemia/Lymphoma Cells: Implications for Resistance to Rituximab

Expansion of donor-derived hematopoietic stem cells with PIGA mutation associated with late graft failure after allogeneic stem cell transplantation

A Novel Strategy for the Treatment of Acute Graft-Versus-Host Disease Using the Adsorbent To Remove Excessive Inflammatory Cytokines.

Monocyte Colony-Stimulating Factor Enhances Rituximab-Dependent Cellular Cytotoxicity by Monocytes.

Clinical Analysis of Adult Acute Leukemia with Rearrangements of the 11q23/MLL: Multicenter Co-Operative Study.

Treatment Outcome of Aggressive Lymphoma with CyclOBEAP (CHOP-Like + Etoposide and Bleomycin): Results of Multicenter Trial.

Disappearance of Cytogenetic Abnormalities Induced by Cyclosporine Therapy in a Case of Aplastic Anemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only